» Articles » PMID: 23134576

Gonadotropin Treatment Augments Postnatal Oogenesis and Primordial Follicle Assembly in Adult Mouse Ovaries?

Overview
Journal J Ovarian Res
Publisher Biomed Central
Date 2012 Nov 9
PMID 23134576
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Follicle stimulating hormone (FSH) exerts action on both germline and somatic compartment in both ovary and testis although FSH receptors (FSHR) are localized only on the somatic cells namely granulosa cells of growing follicles and Sertoli cells in the seminiferous tubules. High levels of FSH in females are associated with poor ovarian reserve, ovarian hyper stimulation syndrome etc. and at the same time FSH acts as a survival factor during in vitro organotypic culture of ovarian cortical strips. Thus a further understanding of FSH action on the ovary is essential. We have earlier reported presence of pluripotent very small embryonic-like stem cells (VSELs express Oct-4A in addition to other pluripotent markers) and their immediate descendants 'progenitors' ovarian germ stem cells (OGSCs express Oct-4B in addition to other germ cell markers) in ovarian surface epithelium (OSE) in various mammalian species including mice, rabbit, monkey, sheep and human. Present study was undertaken to investigate the effect of pregnant mare serum gonadotropin (PMSG) on adult mice ovaries with a focus on VSELs, OGSCs, postnatal oogenesis and primordial follicle assembly.

Methods: Ovaries were collected from adult mice during different stages of estrus cycle and after 2 and 7 days of PMSG (5 IU) treatment to study histo-architecture and expression for FSHR, pluripotent stem cells , meiosis and germ cell specific markers.

Results: PMSG treatment resulted in increased FSHR and proliferation as indicated by increased FSHR and PCNA immunostaining in OSE and oocytes of primordial follicles (PF) besides the granulosa cells of large antral follicles. Small 1-2 regions of multilayered OSE invariably associated with a cohort of PF during estrus stage in control ovary were increased to 5-8 regions after PMSG treatment. This was associated with an increase in pluripotent transcripts (Oct-4A, Nanog), meiosis (Scp-3) and germ cells (Oct-4B, Mvh) specific markers. MVH showed positive immuno staining on germ cell nest-like clusters and at places primordial follicles appeared connected through oocytes.

Conclusions: The results of the present study show that gonadotropin (PMSG) treatment to adult mouse leads to increased pluripotent stem cell activity in the ovaries, associated with increased meiosis, appearance of several cohorts of PF and their assembly in close proximity of OSE. This was found associated with the presence of germ cell nests and cytoplasmic continuity of oocytes in PF. We have earlier reported that pluripotent ovarian stem cells in the adult mammalian ovary are the VSELs which give rise to slightly differentiated OGSCs. Thus we propose that gonadotropin through its action on pluripotent VSELs augments neo-oogenesis and PF assembly in adult mouse ovaries.

Citing Articles

Early menarche and childbirth accelerate aging-related outcomes and age-related diseases: Evidence for antagonistic pleiotropy in humans.

Xiang Y, Tanwar V, Singh P, Follette L, Narayan V, Kapahi P medRxiv. 2024; .

PMID: 39398990 PMC: 11469407. DOI: 10.1101/2024.09.23.24314197.


The dynamic expression of SOX17 in germ cells from human female foetus and adult ovaries after specification.

Luo Y, Jie H, Huang K, Cai B, Zhou X, Liang M Front Endocrinol (Lausanne). 2023; 14:1124143.

PMID: 37576970 PMC: 10422046. DOI: 10.3389/fendo.2023.1124143.


Extremely Active Nano-formulation of Resveratrol (XAR™) attenuates and reverses chemotherapy-induced damage in mice ovaries and testes.

Chhabria S, Takle V, Sharma N, Kharkar P, Pansare K, Tripathi A J Ovarian Res. 2022; 15(1):115.

PMID: 36271409 PMC: 9585716. DOI: 10.1186/s13048-022-01043-8.


Dysfunctional Ovarian Stem Cells Due to Neonatal Endocrine Disruption Result in PCOS and Ovarian Insufficiency in Adult Mice.

Sharma D, Bhartiya D Stem Cell Rev Rep. 2022; 18(8):2912-2927.

PMID: 35834052 DOI: 10.1007/s12015-022-10414-z.


Female germline stem cells: aging and anti-aging.

Hong W, Wang B, Zhu Y, Wu J, Qiu L, Ling S J Ovarian Res. 2022; 15(1):79.

PMID: 35787298 PMC: 9251950. DOI: 10.1186/s13048-022-01011-2.


References
1.
Choi J, Choi K, Auersperg N, Leung P . Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells. Endocr Relat Cancer. 2006; 13(2):641-51. DOI: 10.1677/erc.1.01057. View

2.
Wright C, Hovatta O, Margara R, Trew G, Winston R, Franks S . Effects of follicle-stimulating hormone and serum substitution on the in-vitro growth of human ovarian follicles. Hum Reprod. 1999; 14(6):1555-62. DOI: 10.1093/humrep/14.6.1555. View

3.
Bhartiya D, Shaikh A, Nagvenkar P, Kasiviswanathan S, Pethe P, Pawani H . Very small embryonic-like stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous stem cell therapy. Stem Cells Dev. 2011; 21(1):1-6. DOI: 10.1089/scd.2011.0311. View

4.
Babu P, Jiang L, Sairam A, Touyz R, Sairam M . Structural features and expression of an alternatively spliced growth factor type I receptor for follitropin signaling in the developing ovary. Mol Cell Biol Res Commun. 1999; 2(1):21-7. DOI: 10.1006/mcbr.1999.0139. View

5.
Niikura Y, Niikura T, Tilly J . Aged mouse ovaries possess rare premeiotic germ cells that can generate oocytes following transplantation into a young host environment. Aging (Albany NY). 2010; 1(12):971-8. PMC: 2815754. DOI: 10.18632/aging.100105. View